These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31291026)
21. Degradation and estrogenic activity removal of 17beta-estradiol and 17alpha-ethinylestradiol by ozonation and O3/H2O2. Maniero MG; Bila DM; Dezotti M Sci Total Environ; 2008 Dec; 407(1):105-15. PubMed ID: 18805570 [TBL] [Abstract][Full Text] [Related]
22. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. Kotov A; Falany JL; Wang J; Falany CN J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):137-44. PubMed ID: 10369411 [TBL] [Abstract][Full Text] [Related]
23. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals. Donnachie RL; Johnson AC; Sumpter JP Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376 [TBL] [Abstract][Full Text] [Related]
24. Assessing estrogenic activity of pyrethroid insecticides using in vitro combination assays. Kim IY; Shin JH; Kim HS; Lee SJ; Kang IH; Kim TS; Moon HJ; Choi KS; Moon A; Han SY J Reprod Dev; 2004 Apr; 50(2):245-55. PubMed ID: 15118252 [TBL] [Abstract][Full Text] [Related]
25. Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model. Ankley GT; Jensen KM; Kahl MD; Durhan EJ; Makynen EA; Cavallin JE; Martinović D; Wehmas LC; Mueller ND; Villeneuve DL Aquat Toxicol; 2010 Sep; 99(3):389-96. PubMed ID: 20573408 [TBL] [Abstract][Full Text] [Related]
27. Predicting health effects of exposures to compounds with estrogenic activity: methodological issues. Rudel R Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):655-63. PubMed ID: 9168010 [TBL] [Abstract][Full Text] [Related]
28. 17α-Ethinylestradiol and nonylphenol affect the development of forebrain GnRH neurons through an estrogen receptors-dependent pathway. Vosges M; Kah O; Hinfray N; Chadili E; Le Page Y; Combarnous Y; Porcher JM; Brion F Reprod Toxicol; 2012 Apr; 33(2):198-204. PubMed ID: 21549831 [TBL] [Abstract][Full Text] [Related]
29. Molecular Characterization of Estrogen Receptor Agonists during Sewage Treatment Processes Using Effect-Directed Analysis Combined with High-Resolution Full-Scan Screening. Gwak J; Lee J; Cha J; Kim M; Hur J; Cho J; Kim MS; Jang KS; Giesy JP; Hong S; Khim JS Environ Sci Technol; 2022 Sep; 56(18):13085-13095. PubMed ID: 35973975 [TBL] [Abstract][Full Text] [Related]
30. In vitro estrogenic activity of representative endocrine disrupting chemicals mixtures at environmentally relevant concentrations. Yu H; Caldwell DJ; Suri RP Chemosphere; 2019 Jan; 215():396-403. PubMed ID: 30336316 [TBL] [Abstract][Full Text] [Related]
31. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Landry M; Di Paolo T Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705 [TBL] [Abstract][Full Text] [Related]
32. Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment. Guo J; Sinclair CJ; Selby K; Boxall AB Environ Toxicol Chem; 2016 Jun; 35(6):1550-9. PubMed ID: 26799673 [TBL] [Abstract][Full Text] [Related]
33. Effects of dietary phytoestrogens in vivo and in vitro in rainbow trout and Siberian sturgeon: interests and limits of the in vitro studies of interspecies differences. Latonnelle K; Le Menn F; Kaushik SJ; Bennetau-Pelissero C Gen Comp Endocrinol; 2002 Mar; 126(1):39-51. PubMed ID: 11944965 [TBL] [Abstract][Full Text] [Related]
34. A biomimetic approach to the detection and identification of estrogen receptor agonists in surface waters using semipermeable membrane devices (SPMDs) and bioassay-directed chemical analysis. Rastall AC; Getting D; Goddard J; Roberts DR; Erdinger L Environ Sci Pollut Res Int; 2006 Jul; 13(4):256-67. PubMed ID: 16910124 [TBL] [Abstract][Full Text] [Related]
35. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Navas JM; Segner H Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525 [TBL] [Abstract][Full Text] [Related]
36. Identification of active and inactive agonists/antagonists of estrogen receptor based on Tox21 10K compound library: Binomial analysis and structure alert. Wang J; Huang Y; Wang S; Yang Y; He J; Li C; Zhao YH; Martyniuk CJ Ecotoxicol Environ Saf; 2021 May; 214():112114. PubMed ID: 33711575 [TBL] [Abstract][Full Text] [Related]
37. Estrogenic activity of pharmaceuticals in the aquatic environment. Isidori M; Bellotta M; Cangiano M; Parrella A Environ Int; 2009 Jul; 35(5):826-9. PubMed ID: 19135255 [TBL] [Abstract][Full Text] [Related]
38. Prioritization of pharmaceuticals for potential environmental hazard through leveraging a large-scale mammalian pharmacological dataset. Berninger JP; LaLone CA; Villeneuve DL; Ankley GT Environ Toxicol Chem; 2016 Apr; 35(4):1007-20. PubMed ID: 25772004 [TBL] [Abstract][Full Text] [Related]
39. The utility of vitellogenin as a biomarker of estrogenic endocrine disrupting chemicals in molluscs. Tran TKA; Yu RMK; Islam R; Nguyen THT; Bui TLH; Kong RYC; O'Connor WA; Leusch FDL; Andrew-Priestley M; MacFarlane GR Environ Pollut; 2019 May; 248():1067-1078. PubMed ID: 31091639 [TBL] [Abstract][Full Text] [Related]
40. Biological assessments of a mixture of endocrine disruptors at environmentally relevant concentrations in water following UV/H2O2 oxidation. Chen PJ; Rosenfeldt EJ; Kullman SW; Hinton DE; Linden KG Sci Total Environ; 2007 Apr; 376(1-3):18-26. PubMed ID: 17307231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]